Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 19, 2009
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification
Robert Jordan, Arthur Goff, Annie Frimm, et al.
Journal of Medicinal Chemistry
|
March 6, 2007
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors
Thomas R Bailey, Susan R Rippin, Elizabeth Opsitnick, et al.
Antiviral Research
|
July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023
Jessica R Spengler, Kara Carter, Leen Delang, et al.
The Journal of Infectious Diseases
|
June 2, 2020
Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus
Danielle P Porter, Jessica M Weidner, Laura Gomba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2010
A preclinical model of double- versus single-unit unrelated cord blood transplantation
George E Georges, Vladimir Lesnikov, Szczepan W Baran, et al.
Antimicrobial Agents and Chemotherapy
|
July 11, 2012
Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers
Jarasvech Chinsangaram, Kady M Honeychurch, Shanthakumar R Tyavanagimatt, et al.
Antimicrobial Agents and Chemotherapy
|
October 17, 2012
A novel inhibitor of dengue virus replication that targets the capsid protein
Chelsea M Byrd, Dongcheng Dai, Douglas W Grosenbach, et al.
The New England Journal of Medicine
|
August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge study
John P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2020
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
Michael K Lo, César G Albariño, Jason K Perry, et al.
Scientific Reports
|
March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K Lo, Robert Jordan, Aaron Arvey, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
Antimicrobial Agents and Chemotherapy
|
February 19, 2009
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification
Robert Jordan, Arthur Goff, Annie Frimm, et al.
Journal of Medicinal Chemistry
|
March 6, 2007
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors
Thomas R Bailey, Susan R Rippin, Elizabeth Opsitnick, et al.
Antiviral Research
|
July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023
Jessica R Spengler, Kara Carter, Leen Delang, et al.
The Journal of Infectious Diseases
|
June 2, 2020
Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus
Danielle P Porter, Jessica M Weidner, Laura Gomba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2010
A preclinical model of double- versus single-unit unrelated cord blood transplantation
George E Georges, Vladimir Lesnikov, Szczepan W Baran, et al.
Antimicrobial Agents and Chemotherapy
|
July 11, 2012
Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers
Jarasvech Chinsangaram, Kady M Honeychurch, Shanthakumar R Tyavanagimatt, et al.
Antimicrobial Agents and Chemotherapy
|
October 17, 2012
A novel inhibitor of dengue virus replication that targets the capsid protein
Chelsea M Byrd, Dongcheng Dai, Douglas W Grosenbach, et al.
The New England Journal of Medicine
|
August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge study
John P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2020
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
Michael K Lo, César G Albariño, Jason K Perry, et al.
Scientific Reports
|
March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K Lo, Robert Jordan, Aaron Arvey, et al.
Page
of 15